Literature DB >> 16308946

The molecular basis of prostate cancer.

A Yvonne Olsson1, Colin S Cooper.   

Abstract

Cancer involves accumulation of genetic alterations. This review highlights the alterations in control pathways for cell division, development, DNA repair, angiogenesis and cell death that are believed to be key players in the development of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16308946     DOI: 10.12968/hmed.2005.66.11.20021

Source DB:  PubMed          Journal:  Br J Hosp Med (Lond)        ISSN: 1750-8460            Impact factor:   0.825


  2 in total

1.  Inhibition of prostatic cancer growth by ginsenoside Rh2.

Authors:  Qingchuan Zhang; Bin Hong; Songhua Wu; Tianli Niu
Journal:  Tumour Biol       Date:  2014-11-23

2.  Targeting SMAD3 for inhibiting prostate cancer metastasis.

Authors:  Qing Xia; Chengjiang Li; Pingda Bian; Jue Wang; Shuai Dong
Journal:  Tumour Biol       Date:  2014-07-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.